Treatment of severe orthostatic hypotension with the somatostatin analogue octreotide.
The long-acting somatostatin analogue octreotide was used in a patient with severe orthostatic hypotension resistant to conventional treatment. 0.4 ug/kg octreotide given subcutaneously abolished the postural drop in systolic blood pressure for about four hours and was more effective than a combination of fludrocortisone and pindolol.
Woo
J
J
Department of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin.
Or
K H
KH
Teoh
R
R
Nicholls
M G
MG
D004334:Drug Administration Schedule; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D007262:Infusions, Intravenous; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D015282:Octreotide